Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Nrf2 Activation and Fetal Hemoglobin Induction in Sickle Cell Disease

Sriram Krishnamoorthy, Dipti Gupta, William E. Hobbs, MD PhD, Christine Loh, PhD, David R. Light, Robert Peters, PhD, Sarah Sturtevant, Betty Pace, MD, Yukio Nakamura, Brian Lucas, Benjamin F. Vieira

Blood (2016) 128 (22): 4840.

https://doi.org/10.1182/blood.V128.22.4840.4840

Published: 2016

Journal Articles

Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease

Nicolas V Currier, MD PhD, Gersham Dent, PhD, Paul S. Swerdlow, MD, Willem Birkhoff, MD, Jacobus Burggraaf, MD PhD, Jaspert de Vries, Bsc, Jaladhar Neelavalli, PhD, Muhammad Shahid, MD, Brijesh K Yadav, MS, William E. Hobbs, MD PhD, Ajay Verma, MD PhD

Blood (2016) 128 (22): 4871.

https://doi.org/10.1182/blood.V128.22.4871.4871

Published: 2016

Journal Articles

Beta-Thalassemia Treatment and Complications in Two Large US Insured Population Databases

Nancy Maserejian, ScD, Li Li, MS, Jin Wang, MS, William E. Hobbs, MDPhD, Catherine Madigan, MD

Blood (2015) 126 (23): 3278.

https://doi.org/10.1182/blood.V126.23.3278.3278

Published: 2015

Journal Articles

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Nancy Maserejian, ScD, Cortney Hayflinger, MS, Susan Eaton, MSPH, Catherine Madigan, MD, William E. Hobbs, MDPhD

Blood (2015) 126 (23): 2057.

https://doi.org/10.1182/blood.V126.23.2057.2057

Published: 2015

Journal Articles

Dimethyl Fumarate Induces Fetal Hemoglobin in Sickle Cell Disease

Sriram Krishnamoorthy, PhD, Dipti Gupta, MS, Sarah Sturtevant, Biaoru Li, PhD, Levi C Makala, DVM, MBA, PhD, William E. Hobbs, MDPhD, David R. Light, PhD, Betty Pace, MD

Blood (2015) 126 (23): 410.

https://doi.org/10.1182/blood.V126.23.410.410

Published: 2015

Journal Articles

Natalizumab Blocks VLA-4 Mediated Red Blood Cell Adhesion and Is a Potential Therapy for Sickle Cell Disease

Patrick C. Hines, MD PhD, Sriram Krishnamoorthy, PhD, Jennell White, PhD, Dipti Gupta, MS, Arjan van der Flier, PhD, Moira M. Lancelot, MD, Robert T. Peters, PhD BS, Haiyan Jiang, PhD, William E Hobbs, MD PhD, David R. Light, PhD

Blood (2014) 124 (21): 221.

https://doi.org/10.1182/blood.V124.21.221.221

Published: 2014

Journal Articles

Von Willebrand Factor Activity Increases Following Automated But Not Simple Red Blood Cell Exchange Transfusion In Sickle Cell Disease Patients

William E. Hobbs, II, MD, PhD, Emily E. Moore, Jill M. Johnsen, MD

Blood (2013) 122 (21): 986.

https://doi.org/10.1182/blood.V122.21.986.986

Published: 2013

Journal Articles

Cocaine and Certain of Its Long-Acting Metabolites Stimulate Endothelial Cell Von Willebrand Factor Secretion

William E Hobbs, II, MD, PhD, Rebecca P Penkala, PhD, Emily E Moore, José A. López, MD

Blood (2011) 118 (21): 1148.

https://doi.org/10.1182/blood.V118.21.1148.1148

Published: 2011

Journal Articles

The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma

Junmei Chen, William E. Hobbs, Jennie Le, Peter J. Lenting, Philip G. de Groot, José A. López

Blood (2011) 117 (13): 3680–3683.

https://doi.org/10.1182/blood-2010-08-302539

Published: 2011

Includes: Supplemental data

Journal Articles

Elevated Cytosolic Cyclic AMP Inhibits Platelet Adhesion to Von Willebrand Factor by Disengaging the Glycoprotein Ib-IX-V Complex From Lipid Rafts

Adam D Munday, Rebecca A Penkala, Pavel D Davizon, MD, Clyde J Pierce, William E Hobbs, II, MD, PhD, John D Kulman, PhD, Wendy E Thomas, PhD, Jose A. Lopez, MD

Blood (2010) 116 (21): 3204.

https://doi.org/10.1182/blood.V116.21.3204.3204

Published: 2010

Journal Articles

Shear elegance: regulation of thrombus growth by shear stress

William E. Hobbs, II, José A. López

Blood (2008) 111 (3): 972.

https://doi.org/10.1182/blood-2007-11-119784

Published: 2008

Journal Articles

Vascular Consequences of Cocaine Exposure.

William E. Hobbs, MD, PhD, Chen Jun-Mei, PhD, López A. José, MD

Blood (2007) 110 (11): 3718.

https://doi.org/10.1182/blood.V110.11.3718.3718

Published: 2007

NARROW

Nrf2 Activation and Fetal Hemoglobin Induction in Sickle Cell Disease

Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease

Beta-Thalassemia Treatment and Complications in Two Large US Insured Population Databases

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Dimethyl Fumarate Induces Fetal Hemoglobin in Sickle Cell Disease

Natalizumab Blocks VLA-4 Mediated Red Blood Cell Adhesion and Is a Potential Therapy for Sickle Cell Disease

Von Willebrand Factor Activity Increases Following Automated But Not Simple Red Blood Cell Exchange Transfusion In Sickle Cell Disease Patients

Cocaine and Certain of Its Long-Acting Metabolites Stimulate Endothelial Cell Von Willebrand Factor Secretion

The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma

Elevated Cytosolic Cyclic AMP Inhibits Platelet Adhesion to Von Willebrand Factor by Disengaging the Glycoprotein Ib-IX-V Complex From Lipid Rafts

Shear elegance: regulation of thrombus growth by shear stress

Vascular Consequences of Cocaine Exposure.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only